Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in pancreatic cancer patients. Study author Dr. Cullen and oncologists discuss.

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic ...

While the study focused on pancreatic cancer, Dr. Benga noted potential benefits of high-dose vitamin C in treating breast cancer and glioblastoma, a type of brain cancer.

We designed and implemented a new mitoxantrone-based high-dose chemotherapy regimen to minimize pulmonary injury (seen in carmustine-based regimens) in patients with breast cancer. One hundred and ...

High doses of vitamin C could be a new breakthrough in treating cancer. The University of Iowa Health Care Carver College of Medicine has shared results from a randomized, phase 2 trial testing ...